» Articles » PMID: 35163038

Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Feb 15
PMID 35163038
Authors
Affiliations
Soon will be listed here.
Abstract

Gut microbiota encompasses a wide variety of commensal microorganisms consisting of trillions of bacteria, fungi, and viruses. This microbial population coexists in symbiosis with the host, and related metabolites have profound effects on human health. In this respect, gut microbiota plays a pivotal role in the regulation of metabolic, endocrine, and immune functions. Bacterial metabolites include the short chain fatty acids (SCFAs) acetate (C2), propionate (C3), and butyrate (C4), which are the most abundant SCFAs in the human body and the most abundant anions in the colon. SCFAs are made from fermentation of dietary fiber and resistant starch in the gut. They modulate several metabolic pathways and are involved in obesity, insulin resistance, and type 2 diabetes. Thus, diet might influence gut microbiota composition and activity, SCFAs production, and metabolic effects. In this narrative review, we discuss the relevant research focusing on the relationship between gut microbiota, SCFAs, and glucose metabolism.

Citing Articles

Gut over Mind: Exploring the Powerful Gut-Brain Axis.

Petrut S, Bragaru A, Munteanu A, Moldovan A, Moldovan C, Rusu E Nutrients. 2025; 17(5).

PMID: 40077713 PMC: 11901622. DOI: 10.3390/nu17050842.


Unveiling roles of beneficial gut bacteria and optimal diets for health.

Kumar S, Mukherjee R, Gaur P, Leal E, Lyu X, Ahmad S Front Microbiol. 2025; 16:1527755.

PMID: 40041870 PMC: 11877911. DOI: 10.3389/fmicb.2025.1527755.


The Results of Intestinal Villi of Laying Hens Exposed With Avian Pathogenic (APEC) After Giving Citric Acid and Dextrose.

Warsito S, Lamid M, Al-Arif M, Hermadi H, Sabdoningrum E, Ayuti S Vet Med Int. 2025; 2025:6623764.

PMID: 40041134 PMC: 11876522. DOI: 10.1155/vmi/6623764.


From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease.

Pasta A, Formisano E, Calabrese F, Marabotto E, Furnari M, Bodini G Microorganisms. 2025; 13(2).

PMID: 40005608 PMC: 11857840. DOI: 10.3390/microorganisms13020241.


Advances in Metabolic Bariatric Surgeries and Endoscopic Therapies: A Comprehensive Narrative Review of Diabetes Remission Outcomes.

Ghusn W, Zeineddine J, Betancourt R, Gajjar A, Yang W, Robertson A Medicina (Kaunas). 2025; 61(2).

PMID: 40005466 PMC: 11857516. DOI: 10.3390/medicina61020350.


References
1.
Baothman O, Zamzami M, Taher I, Abubaker J, Abu-Farha M . The role of Gut Microbiota in the development of obesity and Diabetes. Lipids Health Dis. 2016; 15:108. PMC: 4912704. DOI: 10.1186/s12944-016-0278-4. View

2.
Mohammad S, Thiemermann C . Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions. Front Immunol. 2021; 11:594150. PMC: 7829348. DOI: 10.3389/fimmu.2020.594150. View

3.
Derrien M, van Baarlen P, Hooiveld G, Norin E, Muller M, de Vos W . Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. Front Microbiol. 2011; 2:166. PMC: 3153965. DOI: 10.3389/fmicb.2011.00166. View

4.
Kreznar J, Keller M, Traeger L, Rabaglia M, Schueler K, Stapleton D . Host Genotype and Gut Microbiome Modulate Insulin Secretion and Diet-Induced Metabolic Phenotypes. Cell Rep. 2017; 18(7):1739-1750. PMC: 5325228. DOI: 10.1016/j.celrep.2017.01.062. View

5.
Kim M, Kang S, Park J, Yanagisawa M, Kim C . Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology. 2013; 145(2):396-406.e1-10. DOI: 10.1053/j.gastro.2013.04.056. View